Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-05 Purchase |
2020-10-28 8:36 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
42 | $7.8757 | $331 | 110,042 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-04 Option Award |
2021-01-05 4:59 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
137,500 | $0 | 413,996 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:57 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
113,333 | $0 | 277,182 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:55 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
113,333 | $0 | 219,234 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:53 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
137,500 | $0 | 247,542 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:50 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer |
379,000 | $0 | 606,860 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:48 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
113,333 | $0 | 238,626 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:36 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
81,000 | $0 | 110,042 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:32 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
61,000 | $0 | 105,901 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
61,000 | $0 | 163,849 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:28 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
81,000 | $0 | 276,496 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:24 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer |
178,300 | $0 | 227,860 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:22 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
61,000 | $0 | 125,293 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:58 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
16,000 | $0 | 44,901 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:57 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Shah Rajeev M. Director 10% Owner |
20,000 | $0 | 10,894,613 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:56 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
16,000 | $0 | 64,293 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:55 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:54 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director |
20,000 | $0 | 33,064 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:52 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer |
49,560 | $0 | 49,560 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:52 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Paull Robert Bradley Director |
20,000 | $0 | 22,361 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:48 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Grunberg Gregory Director |
20,000 | $0 | 5,431,860 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:47 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K Chief Medical Officer |
19,000 | $0 | 195,496 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:36 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:31 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming Chief Scientific Officer |
16,000 | $0 | 102,849 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:25 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
19,000 | $0 | 29,000 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-22 4:06 pm |
N/A 2029-01-01 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
28,901 | $0 | 165,000 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-22 4:06 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric See Remarks |
28,901 | $5.19 | 165,000 (Direct) |
View |
| 2020-06-09 Exercise |
2020-06-11 4:58 pm |
N/A 2024-10-01 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
43,477 | $0 | 48,293 (Direct) |
View |
| 2020-06-09 Exercise |
2020-06-11 4:58 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
26,880 | $2.3 | 48,293 (Direct) |
View |
| 2020-06-09 Exercise |
2020-06-11 4:58 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer |
5,077 | $5.21 | 48,293 (Direct) |
View |